Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
How to Trip Rapid Review
Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)
Step 2: press
Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.
Escherichia coli (ETEC) diarrhoea. The Cochrane Library. 2011. Footnote 21 DuPont HL, Sullivan P, Evans DG. Prevention of traveler'sdiarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth. J Am Med Assoc. 1980 1980;243(3):237-41. Footnote 22 DuPont HL, Ericsson CD, Johnson PC, Bitsura JA, de la Cabada FJ. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. J Am Med Assoc. 1987;257(10):1347-50. Footnote 23 Steffen R, DuPont HL, Heusser R (...) for prophylaxis against travellers' diarrhoea. J Antimicrob Chemother. 1987;20(4):563-74. Footnote 29 Alajbegovic S, Sanders JW, Atherly DE, Riddle MS. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): A systematic review and meta-analysis. Systematic Reviews. 2009;1(1). Footnote 30 Mackell S. Traveler'sdiarrhea in the pediatric population: Etiology and impact. Clin Infect Dis. 2005 Dec 1;41 Suppl 8:S547-52. Footnote 31 Noel GJ, Bradley JS, Kauffman RE, Duffy CM, Gerbino
, and freshwater or sea water. Potential illness-causing contaminants include human faeces, animal waste, sewage, or wastewater runoff. Do not routinely offer prophylactic treatment for prevention of travellers' diarrhoea, as it is not indicated for most travellers. Antibiotic prophylaxis may be appropriate for certain high-risk travellers. For more information, see the section on . The use of bismuth subsalicylate and probiotics for prophylaxis is not recommended. Antidiarrhoeal drugs (such as loperamide (...) Avoiding routine prophylactic treatment Antibiotic prophylaxis has been shown in studies to give up to 90% protection against developing travellers' diarrhoea, although effectiveness depends on the choice of antibiotic and the area of travel [ ]. However, the World Health Organization (WHO) warns that the use of prophylactic antibiotics is controversial [ ] (with some experts not recommending this [ ]). More recent guidelines also emphasise the growing problem of antibiotic resistance associated
A review of antibiotic prophylaxis for travelerâ€™s diarrhea: past to present As there is rapid increase in international travel to tropical and subtropical countries, there will likely be more people exposed to diarrheal pathogens in these moderate to high risk areas and subsequent increased concern for traveler'sdiarrhea. The disease may appear as a mild clinical syndrome, yet a more debilitating presentation can lead to itinerary changes and hospitalization. As bacterial etiologies (...) to be considered. This article aims to review antibiotic prophylaxis from the 1950s to 2000s, to describe the trend and reasons for different antibiotic use in each decade. We conclude that prophylactic antibiotics should be restricted to some high-risk travelers or short-term critical trips.
Are probiotics and prebiotics effective in the prevention of travellers' diarrhea: A systematic review and meta-analysis. Travellers' diarrhea (TD) impacts annually over 20 million tourists, business travellers and military troops on a worldwide basis. Reliance on antibiotic prophylaxis and educational programs has not lead to a significant reduction in TD rates. Previous reviews of probiotics for TD have not accounted for the strain-specificity of probiotic efficacy nor have investigated
Prophylactic efficacy of probiotics on travelersâ€™ diarrhea: an adaptive meta-analysis of randomized controlled trials The 2017 guideline for the prevention of travelers' diarrhea (TD) by the International Society of Travel Medicine suggested that 'there is insufficient evidence to recommend the use of commercially available prebiotics or probiotics to prevent or treat TD.' However, a meta-analysis published in 2007 reported significant efficacy of probiotics in the prevention of TD (summary
Antibiotic resistance in travellers' diarrhoeal disease, an external perspective. There are many recommendations on the use of antibiotics for prophylaxis and treatment of travellers' diarrhoea (TD). As pharmacists with a special interest in antimicrobial stewardship, we examine and offer our perspective on advice that is recommended to travellers in terms of prevention, treatment and management of TD with a focus on antibiotic use and resistance.Publications on TD were identified through (...) PubMed, Google Scholar and Cochrane Library databases searches using search terms 'travellersdiarrhoea', 'travellersdiarrhoea', 'travellers' diarrhoea' 'guidelines', 'expert opinion', 'expert reviews', 'South Asia' and 'South East Asia' (S and SE Asia), 'antibiotics', 'resistance genes', 'travel advice', 'pharmacists', 'guidelines', 'prevention' and 'treatment'. References of articles were also screened for additional relevant studies.Whilst most guidelines and expert reviews were in agreement
: Centers for Disease Control and Prevention Collaborators: Procter and Gamble New York Center for Travel and Tropical Medicine Information provided by (Responsible Party): Kristina Angelo, Centers for Disease Control and Prevention Study Details Study Description Go to Brief Summary: The purpose of this study is to determine if the use of prophylactic bismuth subsalicylate (BSS) has an effect on the acquisition of travelers' diarrhea (TD) or antimicrobial resistance (AMR) genes in fecal samples among (...) Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Bismuth
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. We performed a randomized double-blind study to determine the efficacy of doxycycline (100 mg daily) in preventing travelers' diarrhea among 39 Peace Corps volunteers during their first five weeks in Kenya. The volunteers took either doxycycline or placebo for three weeks and were observed for an additional two weeks. Nine of 21 taking placebo and one of 18 taking (...) doxycycline had travelers' diarrhea during the treatment period (P = 0.012). The protection seemed to persist for at least one week after the drug was stopped. Enterotoxigenic Escherichia coli was the only pathogen isolated from the placebo group, but was not detected in persons taking doxycycline. None of these organisms were resistant to doxycycline or tetracycline, whereas resistance to tetracyclines and other antibiotics was common among the nonenterotoxigenic Esch. coli. We conclude that doxycycline
Can a galacto-oligosaccharide reduce the risk of traveller'sdiarrhoea? A placebo-controlled, randomized, double-blind study. Diarrhoea is a common medical problem affecting travellers to Asia, Africa and Latin America. The use of prophylactic antimicrobial agents may increase the risk of contracting resistant bacteria. Findings indicate that oligosaccharides, i.e. carbohydrate chains of 3-10 monosaccharides, reduce the risk of diarrhoea.We performed a placebo-controlled, double-blind study (...) of a galacto-oligosaccharide, B-GOS (Bimuno®, Clasado Ltd, Milton Keynes UK), vs placebo for participants travelling to countries with a high/intermediate risk of diarrhoea for 7-15 days. The participants ingested 2.7g of B-GOS daily from 5 days prior to departure throughout the travel period, and returned a questionnaire, with a diarrhoea log, after their return. The case definition of diarrhoea was three or more loose stools per day.Of 523 enrolled subjects, 334 travellers managed to comply per protocol
Medications for the prevention and treatment of travellers' diarrhea. . Travellers' diarrhea (TD) remains one of the most common illnesses encountered by travellers to less developed areas of the world. Because bacterial pathogens such as enterotoxigenic Escherichia coli (ETEC), enteroaggregative E. coli , Campylobacter spp. and Shigella spp. are the most frequent causes, antibiotics have been useful in both prevention and treatment of TD.Results of trials that assessed the use of medications (...) for the prevention and treatment of TD were identified through PubMed and MEDLINE searches using search terms 'travellers' diarrhea', 'prevention' and 'treatment'. References of articles were also screened for additional relevant studies.Prevention of TD with antibiotics has been recommended only under special circumstances. Doxycycline, trimethoprim-sulfamethoxazole, fluoroquinolones and rifaximin have been used for prevention, but at present the first three antibiotics may have limited use secondary
-antibiotic prophylaxis and treatment, utility of available diagnostics, impact of multi-drug resistant (MDR) colonization associated with travel and travelers' diarrhea, and how our understanding of the gastrointestinal microbiome should influence current practice and future research. Studies related to these key clinical areas were assessed for relevance and quality. Based on this critical appraisal, guidelines were developed and voted on using current standards for clinical guideline development (...) methodology.: New definitions for severity of travelers' diarrhea were developed. A total of 20 graded recommendations on the topics of prophylaxis, diagnosis, therapy and follow-up were developed. In addition, three non-graded consensus-based statements were adopted.: Prevention and treatment of travelers' diarrhea requires action at the provider, traveler and research community levels. Strong evidence supports the effectiveness of antimicrobial therapy in most cases of moderate to severe travelers
they travel What to cover: • Give general travel advice on avoiding road traffic accident, drowning incidents and on water and food hygiene • Give prophylaxis for traveller’sdiarrhoea • Explain ABCD of malaria prevention • Recommend malaria personal protection measures • Prescribe malaria prophylaxis • Discuss the need for travel vaccines and refer to a travel service for vaccination by a travel medicine practitioner 3 • Travel insurance is essential and is it essential to declare HIV. If any condition (...) that following these rules reduces the risk of traveller’sdiarrhoea (TD), and prophylaxis and treatment of TD is described later. • Discuss safe sex as appropriate. There is a high risk of first, and multiple, sexual partners in YP whilst travelling. 4 Traveller’sdiarrhoea: prevention and treatment Traveller’sDiarrhoea (TD) affects up to 30% of patients travelling in high-risk areas, where hygiene standards are poor. When the traveller has an immunodeficiency resulting in increased risk of TD, a short
CRACKCast E173 – Infectious Diarrheal Disease and Dehydration CRACKCast E173 - Infectious Diarrheal Disease and Dehydration - CanadiEM CRACKCast E173 – Infectious Diarrheal Disease and Dehydration In , by Chris Lipp April 30, 2018 This episode of CRACKCast covers Rosen’s Chapter 173 (9th Ed.). Infectious diarrhea is a very common issue to deal with in the ER and resulting dehydration is especially important to recognize and treat appropriately. This episode will run you through the basics (...) . Antibiotics are recommended routinely for Campylobacter, C. difficile, Giardia intestinalis, and E. Histolytica. Antibiotics can be considered for Cryptosporidium, traveler’sdiarrhea, and Shigella (because antibiotics have been shown to decrease diarrhea and eradicate organisms in the stool). Patients with Shiga toxin–producing E. coli (STEC) should not empirically receive antibiotics, because they may increase the risk of hemolytic-uremic syndrome (HUS). Testing for fecal leukocytes is a useful initial
the development of the diarrhoea over the previ- ous days and, particularly, the frequency of bowel movements during the past 24 hours. Stool consistency and admixture of blood, mucus or pus should be noted. It is also important to distin- guish diarrhoea from steatorrhoea, according to stool characteris- tics. Questions should cover possible causes other than cancer and oncological therapies [food and ?uid intake in the last few days, re- cent travel, recent use of antibiotics, use of proton pump inhibitors (...) that contain water, salt and sugar. Oral rehydration: Oral rehydration therapy (ORT) is generally appropriate for mild diarrhoea [I, A]. Diluted fruit juices and ?avoured soft drinks along with saltine crackers and broths or soups may meet the ?uid and salt needs in patients with mild ill- ness. Oral rehydration solutions (ORSs), including standard World Health Organization (WHO) ORSs or commercial ORSs may be more appropriate in patients with more severe diarrhoeal disease [II, A]. In elderly patients
Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. A second randomized double-blind study to determine the efficacy of doxycycline, 100 mg daily, for the prevention of travelers' diarrhea was carried out among 50 Peace Corps Volunteers during their first 10 wk in Morocco. The volunteers took either doxycycline or placebo for 3 wk, and were observed for an additional 7 wk. Eleven of 24 taking the placebo and 2 of 26 (...) the effectiveness of doxycycline prophylaxis for travelers' diarrhea.
to use chemoprophylaxis, only 24% had been prescribed an appropriate drug regimen (31). In a Canadian case series of malaria diagnoses, the vast majority of cases were among travellers who did not seek pre-travel advice and/or were not taking appropriate malaria prophylaxis (32,33). VFRs should be targeted for counselling regarding the importance of malaria prevention, including addressing potential misconceptions regarding personal risk. VFRs travelling to malaria-endemic regions should be advised (...) for work (e.g. health care worker). For individuals at risk of hepatotoxicity from LTBI treatment with isoniazid, such treatment would be reserved for those with recent infection during travel, making pre-travel TB skin testing important for immigrant VFRs who are more likely to have a positive test result pre-travel. PARASITIC INFECTIONS When compared to other travellers, immigrant VFRs have been found to have significantly more non-diarrheal intestinal parasitic infections, regardless of destination
with study drug and placebo during the period of prophylaxis and through the last clinic visit. [ Time Frame: 7 weeks ] To assess the effectiveness of CBS 2004 by evaluating the development of traveler'sdiarrhea (TD) with CBS-2004 versus placebo based on time to first unformed stool associated with a TD episode [ Time Frame: 7 weeks ] Secondary Outcome Measures : Assess the number of work days lost due to diarrhea [ Time Frame: 7 weeks ] Assess percentages of subjects requiring treatment for diarrhea (...) Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Clinical Trial of CBS-2004
intervention in reducing cases and workload. 6 1 Issue Residents of Peel region travel routinely to countries that put them at increased risk of travel- related communicable diseases. Many of these diseases are preventable through vaccination, prophylactic medication or personal protective measures. In 2010, Peel’s rates of typhoid and paratyphoid fever averaged four times higher than provincial rates (Table 1). Peel rates of these diseases, along with hepatitis A and malaria, have remained consistently (...) . available g 7 21 34 10 72 Age of cases (years) Mean: 25 Median: 14 Range: 7-62 Mean: 39 Median: 43 Range: 3-83 Mean: 21 Median: 20 Range: 1-79 Mean: 23 Median: 24 Range: 4-45 Mean: 27 Median: 25 Range: 1-83 Male 43% 81% 41% 80% 58% Vaccination and prophylaxis uptake 0% vaccinated 5% completed malaria prophylaxis 3% vaccinated not applicable 3% gg Pre-travel consultation 0% 24% 9% 10% 13% Most common country of travel Pakistan (57%) Nigeria (29%) India (82%) India (70%) India (56%) Visiting friends
role; speaker's bureau; research funding; patents, royalties, other intellectual property; expert testimony; travel, accommodations, expenses; and other relationships. In accordance with the Policy, the majority of the members of the Expert Panel did not disclose any relationships constituting a conflict under the Policy. RECOMMENDATIONS Section: provides a summary of antimicrobial prophylaxis recommendations. CLINICAL QUESTION 1 Antibacterial Prophylaxis. Does antibacterial prophylaxis (...) Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update | Journal of Clinical Oncology Search in: Menu Article Tools ASCO SPECIAL ARTICLE Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.18.00374 Journal of Clinical Oncology - published online before print September 4, 2018